Infective Endocarditis — Diagnosis and Treatment

Key Points

• Obtain multiple blood-culture sets before antibiotics when the patient is stable enough.
• S. aureus bacteremia should trigger an endocarditis assessment rather than being treated as an uncomplicated bloodstream infection automatically.
• TEE is required when TTE is negative but suspicion remains high and is especially important with prosthetic valves or intracardiac devices.
• Pathogen-directed bactericidal therapy usually continues for weeks and should be narrowed once microbiology is known.
• MSSA endocarditis is generally treated with a beta-lactam rather than vancomycin when tolerated.
• Heart failure, abscess, persistent infection, prosthetic complications, and high embolic risk are major surgical indications.
• New atrioventricular block can indicate perivalvular abscess.
• Management is best coordinated by a multidisciplinary endocarditis team including cardiology, infectious disease, cardiac surgery, microbiology, and imaging specialists.

Algorithm

1. Recognize persistent bacteremia, fever with cardiac risk factors, embolic phenomena, or new valvular dysfunction.
2. Draw at least three blood-culture sets and obtain baseline labs before antibiotics when feasible.
3. Perform TTE, then TEE for high suspicion, prosthetic material, device infection, or nondiagnostic TTE.
4. Start empiric antibiotics if unstable and narrow promptly when cultures and susceptibility are available.
5. Apply contemporary diagnostic criteria using microbiology, echocardiography, and multimodality imaging.
6. Assess daily for heart failure, abscess, conduction disease, emboli, and persistent bacteremia.
7. Engage cardiac surgery early when a surgical indication is present rather than waiting for antibiotics to finish.
8. Complete prolonged organism-directed therapy and establish follow-up for valve function, recurrence, oral health, and prevention.

Clinical Synopsis & Reasoning

Presentation ranges from acute sepsis with a new murmur to weeks of fever, malaise, weight loss, back pain, embolic stroke, splenic infarct, kidney injury, or skin findings. Risk factors include prosthetic valves, previous endocarditis, congenital heart disease, hemodialysis, injection drug use, intracardiac devices, and recent bacteremia. Draw at least three sets of blood cultures from separate venipunctures before antibiotics in a stable patient; in septic shock, obtain cultures rapidly and treat without delay. S. aureus bacteremia carries a high endocarditis risk and warrants focused evaluation. Transthoracic echocardiography is usually first, but transesophageal echo is substantially more sensitive for vegetations, abscess, prosthetic valves, and device infection and is required when suspicion remains high despite a negative TTE. Repeat imaging is appropriate when early studies are nondiagnostic and clinical suspicion persists. The 2023 ESC guideline expands multimodality imaging, including cardiac CT and nuclear imaging, particularly for prosthetic-valve and device-associated infection. Examine for heart failure, conduction block, neurologic deficits, limb or mesenteric ischemia, vertebral pain, and peripheral embolic or immune manifestations. Culture-negative disease requires review of prior antibiotics and testing for fastidious organisms.

Treatment Strategy & Disposition

Antibiotic choice depends on native versus prosthetic valve, organism, susceptibility, allergy, kidney function, and prior antibiotics. Avoid committing to a prolonged empiric regimen before adequate cultures when the patient is stable. For acutely ill native-valve disease, empiric therapy commonly covers S. aureus, streptococci, and enterococci, with local protocols guiding exact agents. Once cultures identify the pathogen, narrow promptly and use guideline-specific bactericidal regimens for the required duration, usually several weeks. MSSA should be treated with an antistaphylococcal beta-lactam when possible rather than vancomycin. Remove infected cardiac devices when indicated. Early surgical consultation is required for acute severe valve regurgitation with heart failure, uncontrolled infection or abscess, fungal or difficult-to-eradicate prosthetic infection, persistent bacteremia despite active therapy, and selected large vegetations with embolic risk. Neurologic emboli do not automatically preclude surgery; timing depends on ischemic versus hemorrhagic stroke and cardiac urgency. Search for metastatic infection such as vertebral osteomyelitis, splenic abscess, or mycotic aneurysm when symptoms suggest it.

Epidemiology / Risk Factors

• S. aureus is a leading cause of infective endocarditis in many modern cohorts.
• Streptococci and enterococci remain major pathogens, with distributions differing by community, health care exposure, and valve type.
• Prosthetic valves and intracardiac devices have increased the complexity of contemporary disease.
• Injection drug use produces a younger population with frequent right-sided S. aureus infection.
• Incidence rises with age, hemodialysis, degenerative valve disease, and invasive health care.

Investigations

Typical Regimens (Abbrev.)

Pharmacology

Prognosis / Complications

• In-hospital mortality remains high despite modern antimicrobial and surgical care.
• Heart failure, S. aureus infection, prosthetic-valve disease, periannular abscess, stroke, and persistent bacteremia worsen prognosis.
• Appropriate early surgery can be lifesaving when severe valve dysfunction or uncontrolled infection is present.
• Relapse suggests inadequate duration, uncontrolled source, infected prosthetic material, or difficult microbiology.
• Survivors require follow-up echocardiography and education about recurrence and prophylaxis indications.

Patient Education / Counseling

• Complete the full antimicrobial course and attend all blood-culture, infusion, surgical, and cardiology follow-up.
• Seek urgent care for recurrent fever, new weakness or speech change, severe back pain, abdominal pain, chest pain, or breathlessness.
• Maintain excellent dental hygiene and understand whether you qualify for antibiotic prophylaxis before selected dental procedures.
• Do not inject into vascular access used for antimicrobial therapy and discuss substance-use treatment when relevant.
• Explain that surgery may be needed during active infection and is not necessarily a sign that antibiotics have failed; it often addresses mechanical valve destruction or an infected abscess that drugs cannot fix alone.

Notes

Infective endocarditis is both an infection and a structural heart disease emergency. Antibiotics sterilize blood and vegetations, but they cannot reliably repair a destroyed valve, drain every abscess, or remove infected device material. That is why early diagnosis depends on blood cultures and high-quality imaging, and why surgery is considered during active infection rather than only after a full antibiotic course. The endocarditis-team model brings microbiology, imaging, antimicrobial therapy, embolic risk, and cardiac mechanics into one coordinated plan.

References

1. 2023 ESC Guidelines for the Management of Endocarditis — Link